EFFICACY AND SAFETY OF INTRAVENOUS USTEKINUMAB RE-INDUCTION THERAPY IN CROHN'S DISEASE PATIENTS WITH SECONDARY LOSS OF RESPONSE TO USTEKINUMAB MAINTENANCE THERAPY: WEEK 16 RESULTS FROM THE POWER TRIAL

被引：0
|
作者：
Lee, Scott D.
Schreiber, Stefan
Janneke, Christien
Van der Woude
Marin-Jimenez, Ignacio
Wolf, Douglas C.
Schnoy, Elisabeth
Salzberg, Bruce
Busse, Christopher
Nazar, Maciej
Langholff, Wayne
Borghorst, Stephan
Gasink, Christopher
Baker, Thomas
Godwin, Bridget
Feagan, Brian G.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1027
引用
收藏
页码：S220 / S220
页数：1
相关论文
共 50 条
  • [21] Efficacy of ustekinumab for induction and maintenance of histological healing in patients with Crohn's disease
    Li, K.
    Chan, D.
    Pollack, P.
    Jacobstein, D.
    Brodmerkel, C.
    Gasink, C.
    Feagan, B. G.
    Sandborn, W.
    Rutgeerts, P.
    De Hertogh, G.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S314 - S314
  • [22] Efficacy and safety of ustekinumab as maintenance therapy in ulcerative colitis: Week 44 results from the UNIFI study
    Sands, B.
    Sandborn, W.
    Pannacione, R.
    O'Brien, C.
    Leong, R.
    Zhang, H.
    Johanns, J.
    Peyrin-Biroulet, L.
    Van Assche, G.
    Danese, S.
    Targan, S.
    Abreu, M.
    Hisamatsu, T.
    Szapary, P.
    Marano, C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 129 - 130
  • [23] Efficacy and Safety of Ustekinumab (UST) as Maintenance Therapy in Ulcerative Colitis: Week 44 Results from UNIFI
    Marone, Colleen
    Sandborn, William J.
    Sands, Bruce E.
    Panaccione, Remo
    O'Brien, Christopher D.
    Zhang, Hongyan
    Johanns, Jewel
    Peyrin-Biroulet, Laurent
    van Assche, Gert
    Danese, Silvio
    Targan, Stephan
    Abreu, Maria T.
    Hisamatsu, Tadakazu
    Szapary, Philippe
    SWISS MEDICAL WEEKLY, 2019, : 27S - 27S
  • [24] Re-Induction of Intravenous, Weight-Based Ustekinumab Is Well Tolerated in Patients With Moderate-Severe Crohn's Disease
    Lee, Scott D.
    Kamp, Kendra
    Clark-Snustad, Kindra
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S339 - S340
  • [25] Letter: optimising response to ustekinumab therapy for patients with Crohn's disease
    Hudson, Joshua
    Herfarth, Hans H.
    Barnes, Edward L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (05) : 906 - 906
  • [26] Efficacy and safety of ustekinumab through Week 16 in patients with moderate to severe ulcerative colitis: Results from the UNIFI induction trial
    Danese, S.
    Sands, B.
    O'Brien, C.
    Zhang, H.
    Johanns, J.
    Sloan, S.
    Izanek, J.
    Szapary, P.
    Marano, C.
    Leong, R.
    Rowbotham, D.
    Targan, S.
    Van Assche, G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 130 - 131
  • [27] Single or continuous multiple intravenous re-induction in Crohn's disease patients who lost response to ustekinumab: Evidence from real-world data
    Tang, Jian
    Li, Qing
    Huang, Zhaopeng
    Shi, Lishuo
    Guo, Qin
    Li, Miao
    Gao, Xiang
    Chao, Kang
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (05) : 749 - 755
  • [28] Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's Disease
    Colombel, Jean-Frederic
    Sands, Bruce E.
    Gasink, Christopher
    Yeager, Benjamin
    Adedokun, Omoniyi J.
    Izanec, James
    Ma, Tony
    Gao, Long -Long
    Lee, Scott D.
    Targan, Stephan R.
    Ghosh, Subrata
    Hanauer, Stephen B.
    Sandborn, William J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (01) : 144 - 153.e2
  • [29] Efficacy of Ustekinumab Intravenously q12 Weeks for Maintenance Therapy for Crohn's Disease
    Masood, Hamza
    Waghela, Rajdeepsingh
    Amini, Shayan
    Fan, Christopher
    Abraham, Bincy P.
    ACG CASE REPORTS JOURNAL, 2024, 11 (10)
  • [30] Efficacy of Ustekinumab Intravenously q12 Weeks for Maintenance Therapy for Crohn's Disease
    Masood, Hamza
    Amini, Shayan
    Waghela, Rajdeepsingh
    Abraham, Bincy
    Fan, Christopher
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S2138 - S2139
12345